4.2 Review

Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective

期刊

TOXICOLOGY MECHANISMS AND METHODS
卷 28, 期 5, 页码 369-385

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/15376516.2017.1422580

关键词

3D models; drug biotransformation; drug toxicity; in vitro models; liver dysfunction

资金

  1. National Research Foundation (NRF) of South Africa [91460]
  2. South African Medical Research Council (MRC) under Self-Initiated Research grant
  3. DrugMode A/S and MC2 Biotek (Denmark)
  4. COST actions [CM1407, CA16119]

向作者/读者索取更多资源

The liver is a vital organ fulfilling a central role in over 500 major metabolic functions, including serving as the most essential site for drug biotransformation. Dysfunction of the drug biotransformation processes may result in the exposure of the liver (and other organs) to hepatotoxins, potentially interacting with cellular constituents and causing toxicity and various lesions. Hepatotoxicity can be investigated on a tissue, cellular and molecular level by employing various in vivo and in vitro techniques, including novel three-dimensional (3D) cell culturing methods. This paper reflects on the liver and its myriad of functions and the influence of drug biotransformation on liver dysfunction. Current in vivo and in vitro models used to study liver function and dysfunction is outlined, emphasizing their advantages and disadvantages. The advantages of novel in vitro 3D cell culture models are discussed and the possibility of novel models to bridge the gap between in vitro and in vivo models is explained. Progression made in the field of cell culturing methods such as 3D cell culturing techniques over the last decade promises to reduce the use of in vivo animal models in biotransformation and toxicological studies of the liver.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据